drugset / Trial / NCT00169442
Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants
RandomizedParallel-groupOpen-labelPrevention
Summary
To assess the immune memory following primary vaccination of DTPw-HBV/Hib vaccine and to assess immunogenicity and reactogenicity of a booster dose given at 15 - 18 months of age.
Timeline
- Start
- 2005-02-10
- Primary completion
- 2006-03-01
- Completion
- 2006-03-10
Publications
- Background Gatchalian et al. A new DTPw-HBV/Hib vaccine: Immunogenic and safe for primary vaccination and booster dosing in the second year of life - 5th World Congress WSPID, Bangkok, Thailand, 15-18 Nov 2007
- Background Gatchalian S, Reyes M, Bermal N, Chandrasekaran V, Han HH, Bock HL, Lefevre I. A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life. Hum Vaccin. 2008 Jan-Feb;4(1):60-6. doi: 10.4161/hv.4.1.5069. Epub 2007 Sep 23.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN | Vaccine | — | Intramuscular |
| Subject | Polyribosil-Ribitol-Phosphate (PRP) vaccine | Vaccine | — | Intramuscular |
| Subject | Tritanrix™-HepB Kft | Vaccine | — | Intramuscular |
| Subject | Tritanrix™-HepB/Hiberix™ Kft. | Vaccine | — | Intramuscular |